Evidence map›Paper›PMID 41663769›Full record

ArticleAesthetic plastic surgery2026

Current Approaches in Periocular Rejuvenation: Our 6-year Experience.

Yael Lustig-Barzelay, Daphna Landau-Prat, Guy J Ben-Simon

Abstract read
PubMed Publisher
In one paragraph

Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yael Lustig-BarzelayOrbital Ophthalmic Plastic & Lacrimal Surgery Institute, Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel.
Daphna Landau-PratOrbital Ophthalmic Plastic & Lacrimal Surgery Institute, Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel.
Guy J Ben-SimonOrbital Ophthalmic Plastic & Lacrimal Surgery Institute, Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel. guybensimon@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeriocular rejuvenation involves surgical removal of excess skin, fat debulking, or transfer, and optionally includes eyelid ptosis repair or lateral canthal resuspension. Periocular injectables have revolutionized these esthetic treatments, sometimes replacing surgery. We describe our experience with current treatment approaches for periocular rejuvenation of upper and lower eyelids.

methodsWe extracted data on treatment types and outcomes of all patients treated for periocular rejuvenation of upper and lower eyelids between 2015 and 2020. All patients were treated by a single surgeon (GBS) at three medical centers. Outcome measures included demographic trends, procedural frequencies, age and gender distribution, as well as age-stratified preferences for surgical versus injectable treatments.

resultsIn total, 1923 patients (mean age 64 years, 1340 females [70%]) underwent upper eyelid rejuvenation, and 248 underwent lower eyelid rejuvenation. Upper eyelid ptosis correction was the most common surgery (1048 patients [55%]), followed by blepharoplasty (875 patients [45%]). Transconjunctival fat debulking with skin pinch removal was the most common surgical approach for lower eyelids (158 patients [64%]), followed by transconjunctival alone (40 patients [16%], canthopexy, and fat repositioning. Additionally, 154 patients underwent 231 periocular hyaluronic acid injections, mostly for tear-trough deformity and retro-orbicularis oculi fat pad to conceal deep superior sulcus deformity. These latter patients were significantly younger than those undergoing surgical treatment. Based on our clinical experience, hyaluronic acid (HA) injections were typically selected for patients with good skin tone and minimal fat herniation who preferred a non-surgical approach.

conclusionsPtosis surgery was performed in over 50% of patients undergoing upper eyelid surgery. Transconjunctival fat debulking with skin pinch removal was the most common surgical approach in our experience. HA injection was particularly useful for correcting deep superior sulcus deformity and was often preferred by patients seeking subtle volume restoration without surgery. Periocular fillers may sometimes be better than lower eyelid blepharoplasty. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Indexed as

BlepharoplastyBlepharoptosisRejuvenationAdultAgedDermal FillersEyelidsFemaleHumansMaleMiddle AgedRetrospective StudiesSkin AgingTreatment OutcomeDermal FillersBlepharoplastyHyaluronic acid injectionsPeriocular rejuvenationUpper eyelid ptosis repair

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.